FEATURED ARTICLES
Notes on being labelled ‘paranoid schizophrenic’
On hearing voices, dissociation & being labelled - ugh! - ‘paranoid schizophrenic’.
I may go about my life, like most other people, maintaining my place of abode, holding down a fulfilling job, keeping contacts with...
Research: Draft mental health law retains coercive elements, does not realise human rights
A new article in the International Journal of Law and Psychiatry critically examines proposed reforms to Irish mental health law, finding that it falls short of delivering the comprehensive changes required by the UN...
NEWS FEED
Research: Draft mental health law retains coercive elements, does not realise human rights
A new article in the International Journal of Law and Psychiatry critically examines proposed reforms...
Part 3: Neuro-authenticity, neuro-identities, and the neuro-industry
Mad in America and Mad in the UK are jointly publishing this four-part series on...
Science news: Placebo effect for all psychiatric diagnoses “of considerable magnitude”
In a new study, researchers found huge improvements in psychiatric symptoms on placebo alone, particularly...
Professionals to speak up about harm caused by mental health practices at UCC conference
This year's Critical Voices Network Ireland will tackle the subject of ‘iatrogenic harm’ - potentially...
Conflicts of interest: psychiatry under the influence of big pharma?
The President of the College of Psychiatrists of Ireland (CPI), Dr Lorcan Martin, received more...
Mad in Ireland social
From Mad in America
Doctors Paid to Market Drugs on Social Media
Adverse Childhood Experiences Dramatically Increase Depression Risk
Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction
For Teen Girls, Rare Psychiatric Disorders Spread Like Viruses on Social Media
Focusing on Trauma and Involving Families in Care Could Help Prevent Early Death
Antidepressants No Better Than Placebo for About 85% of People
RESEARCH
Led by researchers in Trinity College Dublin, the PROTECT Study, seeks to identify priorities for future research on reducing and stopping psychiatric medications. Interested parties take a survey on questions that users would like to see addressed. Take the survey here.
